Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population

Abstract Neuromuscular diseases (NMD) are a group of neurological diseases that manifest with various clinical symptoms affecting different components of the peripheral nervous system, which play a role in voluntary body movements control. The primary objective of this study is to explore the diagno...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah Al-Hedaithy, Fouad Alghamdi, Momen Almomen, Fawzia Amer, Shaikhah Al Dossari, Deeba Noreen Baig, Shahid Bashir
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-81744-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559631087796224
author Abdullah Al-Hedaithy
Fouad Alghamdi
Momen Almomen
Fawzia Amer
Shaikhah Al Dossari
Deeba Noreen Baig
Shahid Bashir
author_facet Abdullah Al-Hedaithy
Fouad Alghamdi
Momen Almomen
Fawzia Amer
Shaikhah Al Dossari
Deeba Noreen Baig
Shahid Bashir
author_sort Abdullah Al-Hedaithy
collection DOAJ
description Abstract Neuromuscular diseases (NMD) are a group of neurological diseases that manifest with various clinical symptoms affecting different components of the peripheral nervous system, which play a role in voluntary body movements control. The primary objective of this study is to explore the diagnostic efficacy of a combined genetic and biochemical testing approach for patients with neuromuscular diseases with diverse presentations in a population with high rate of consanguinity. Genetic testing was performed using selected Next Generation Sequencing (NGS) gene panels and whole exome sequencing on the peripheral blood sample from the patients. The study results revealed that the majority of patients in our cohort had a history of consanguinity (83%). Genetic testing through gene panels and Whole Exome Sequencing yielded similar result. Out of the patients tested, 66% underwent gene panels testing, 56% had Whole Exome Sequencing, 32% received array Comparative Genomic Hybridization (CGH) assays, and 40% underwent metabolic testing. Overall, 58 patients (61%) received definitive results after following all tests. Among the remaining 36 patients, 19 exhibited variants of unknown significance (VOUS) (21%).
format Article
id doaj-art-f2bcc271b63a446b993745586ec03baf
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f2bcc271b63a446b993745586ec03baf2025-01-05T12:21:45ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-024-81744-wComparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous populationAbdullah Al-Hedaithy0Fouad Alghamdi1Momen Almomen2Fawzia Amer3Shaikhah Al Dossari4Deeba Noreen Baig5Shahid Bashir6Department of Pediatric Neurology, Neuroscience Center, King Fahad Specialist HospitalDepartment of Pediatric Neurology, Neuroscience Center, King Fahad Specialist HospitalDepartment of Pediatric Neurology, Neuroscience Center, King Fahad Specialist HospitalDepartment of Pediatric Neurology, Neuroscience Center, King Fahad Specialist HospitalNeuroscience Center, King Fahad Specialist HospitalSchool of Life Sciences, Forman Christian College (A Chartered University) LahoreNeuroscience Center, King Fahad Specialist HospitalAbstract Neuromuscular diseases (NMD) are a group of neurological diseases that manifest with various clinical symptoms affecting different components of the peripheral nervous system, which play a role in voluntary body movements control. The primary objective of this study is to explore the diagnostic efficacy of a combined genetic and biochemical testing approach for patients with neuromuscular diseases with diverse presentations in a population with high rate of consanguinity. Genetic testing was performed using selected Next Generation Sequencing (NGS) gene panels and whole exome sequencing on the peripheral blood sample from the patients. The study results revealed that the majority of patients in our cohort had a history of consanguinity (83%). Genetic testing through gene panels and Whole Exome Sequencing yielded similar result. Out of the patients tested, 66% underwent gene panels testing, 56% had Whole Exome Sequencing, 32% received array Comparative Genomic Hybridization (CGH) assays, and 40% underwent metabolic testing. Overall, 58 patients (61%) received definitive results after following all tests. Among the remaining 36 patients, 19 exhibited variants of unknown significance (VOUS) (21%).https://doi.org/10.1038/s41598-024-81744-wNeuromuscular diseasesGenetic testingMetabolic profilingConsanguineous populationGene panelsWhole genome sequencing
spellingShingle Abdullah Al-Hedaithy
Fouad Alghamdi
Momen Almomen
Fawzia Amer
Shaikhah Al Dossari
Deeba Noreen Baig
Shahid Bashir
Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
Scientific Reports
Neuromuscular diseases
Genetic testing
Metabolic profiling
Consanguineous population
Gene panels
Whole genome sequencing
title Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
title_full Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
title_fullStr Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
title_full_unstemmed Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
title_short Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
title_sort comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population
topic Neuromuscular diseases
Genetic testing
Metabolic profiling
Consanguineous population
Gene panels
Whole genome sequencing
url https://doi.org/10.1038/s41598-024-81744-w
work_keys_str_mv AT abdullahalhedaithy comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT fouadalghamdi comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT momenalmomen comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT fawziaamer comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT shaikhahaldossari comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT deebanoreenbaig comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation
AT shahidbashir comparativegeneticdiagnosticevaluationofpediatricneuromusculardiseasesinaconsanguineouspopulation